These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11379843)

  • 1. Optimal dosing with risperidone: updated recommendations.
    Williams R
    J Clin Psychiatry; 2001 Apr; 62(4):282-9. PubMed ID: 11379843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone dosing pattern and clinical outcome in psychosis: an analysis of 1713 cases.
    Kim CY; Shin YW; Joo YH; Hong JP; Lee GH; Choi SK
    J Clin Psychiatry; 2005 Jul; 66(7):887-93. PubMed ID: 16013904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone use at a state hospital: a clinical audit 2 years after the first wave of risperidone prescriptions.
    Chengappa KN; Sheth S; Brar JS; Parepally H; Marcus S; Gopalani A; Palmer A; Baker RW; Schooler NR
    J Clin Psychiatry; 1999 Jun; 60(6):373-8. PubMed ID: 10401915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration in the recommended dosing schedule for risperidone.
    Luchins DJ; Klass D; Hanrahan P; Malan R; Harris J
    Am J Psychiatry; 1998 Mar; 155(3):365-6. PubMed ID: 9501746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing of antipsychotics in UK primary care: a cohort study.
    Marston L; Nazareth I; Petersen I; Walters K; Osborn DP
    BMJ Open; 2014 Dec; 4(12):e006135. PubMed ID: 25524544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone.
    Feifel D; Moutier CY; Perry W
    J Clin Psychiatry; 2000 Dec; 61(12):909-11. PubMed ID: 11206594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
    Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E
    Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-outcome analysis of risperidone.
    Love RC; Conley RR; Kelly DL; Bartko JJ
    J Clin Psychiatry; 1999 Nov; 60(11):771-5. PubMed ID: 10584767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients.
    Taylor DM; Young CL; Mace S; Patel MX
    J Clin Psychiatry; 2004 Aug; 65(8):1076-83. PubMed ID: 15323592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD).
    Vieta E; Herraiz M; Fernández A; Gastó C; Benabarre A; Colom F; Martínez-Arán A; Reinares M
    J Clin Psychiatry; 2001 Aug; 62(8):623-30. PubMed ID: 11561935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L; Jaffe A; Levine J
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series.
    Madhusoodanan S; Brenner R; Araujo L; Abaza A
    J Clin Psychiatry; 1995 Nov; 56(11):514-8. PubMed ID: 7592504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.
    Kinon BJ; Basson BR; Gilmore JA; Malcolm S; Stauffer VL
    J Clin Psychiatry; 2000 Nov; 61(11):833-40. PubMed ID: 11105736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospitalization risk in patients with schizophrenia before and after initiation of risperidone long-acting injection in Japan.
    Yoshimura B; Shinkawa I; Konishi A
    Asian J Psychiatr; 2015 Apr; 14():67-8. PubMed ID: 25736075
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.